Yihong Wan

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. ncbi Bone marrow mesenchymal stem cells: Fat on and blast off by FGF21
    Yihong Wan
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA Electronic address
    Int J Biochem Cell Biol 45:546-9. 2013
  2. ncbi Rosiglitazone activation of PPARgamma suppresses fractalkine signaling
    Yihong Wan
    Department of Pharmacology, University of Texas Southwestern Medical Center, 6001 Forest Park Road, Room ND8 502B, Dallas, Texas 75390 9041, USA
    J Mol Endocrinol 44:135-42. 2010
  3. ncbi PPARγ in bone homeostasis
    Yihong Wan
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Trends Endocrinol Metab 21:722-8. 2010
  4. ncbi Osteoclast progenitors reside in the peroxisome proliferator-activated receptor γ-expressing bone marrow cell population
    Wei Wei
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9041, USA
    Mol Cell Biol 31:4692-705. 2011
  5. ncbi Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ
    Wei Wei
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Proc Natl Acad Sci U S A 109:3143-8. 2012
  6. ncbi Wnt signaling activation in adipose progenitors promotes insulin-independent muscle glucose uptake
    Daniel Zeve
    Department of Developmental Biology, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390 9133, USA
    Cell Metab 15:492-504. 2012
  7. ncbi Biphasic and dosage-dependent regulation of osteoclastogenesis by β-catenin
    Wei Wei
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9041, USA
    Mol Cell Biol 31:4706-19. 2011
  8. ncbi Macrophage VLDL receptor promotes PAFAH secretion in mother's milk and suppresses systemic inflammation in nursing neonates
    Yang Du
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    Nat Commun 3:1008. 2012
  9. ncbi PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss
    Wei Wei
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Cell Metab 11:503-16. 2010
  10. ncbi Maternal western diet causes inflammatory milk and TLR2/4-dependent neonatal toxicity
    Yang Du
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    Genes Dev 26:1306-11. 2012

Collaborators

Detail Information

Publications13

  1. ncbi Bone marrow mesenchymal stem cells: Fat on and blast off by FGF21
    Yihong Wan
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA Electronic address
    Int J Biochem Cell Biol 45:546-9. 2013
    ..These new findings will further elucidate the dynamic regulation of BMMSCs in the pathophysiological control of skeletal homeostasis, and facilitate the clinical applications of BMMSCs in regenerative medicine...
  2. ncbi Rosiglitazone activation of PPARgamma suppresses fractalkine signaling
    Yihong Wan
    Department of Pharmacology, University of Texas Southwestern Medical Center, 6001 Forest Park Road, Room ND8 502B, Dallas, Texas 75390 9041, USA
    J Mol Endocrinol 44:135-42. 2010
    ..Together, these data suggest that PPARgamma activation represses FKN signaling. These findings indicate a previously unrecognized mechanism that may contribute to the anti-inflammatory effect of PPARgamma...
  3. ncbi PPARγ in bone homeostasis
    Yihong Wan
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Trends Endocrinol Metab 21:722-8. 2010
    ..Therefore, PPARγ plays dual roles in bone homeostasis by regulating both mesenchymal and hematopoietic lineages...
  4. ncbi Osteoclast progenitors reside in the peroxisome proliferator-activated receptor γ-expressing bone marrow cell population
    Wei Wei
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9041, USA
    Mol Cell Biol 31:4692-705. 2011
    ..These findings not only identify the long-sought-after osteoclast progenitors but also establish unprecedented tools for their visualization, isolation, characterization, and genetic manipulation...
  5. ncbi Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ
    Wei Wei
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Proc Natl Acad Sci U S A 109:3143-8. 2012
    ..Therefore, FGF21 is a critical rheostat for bone turnover and a key integrator of bone and energy metabolism. These results reveal that skeletal fragility may be an undesirable consequence of chronic FGF21 administration...
  6. ncbi Wnt signaling activation in adipose progenitors promotes insulin-independent muscle glucose uptake
    Daniel Zeve
    Department of Developmental Biology, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390 9133, USA
    Cell Metab 15:492-504. 2012
    ..Thus, adipose progenitor Wnt activation dissociates lipodystrophy from dysfunctional metabolism and highlights a fat-muscle endocrine axis, which may represent a potential therapy to lower blood glucose and improve metabolism...
  7. ncbi Biphasic and dosage-dependent regulation of osteoclastogenesis by β-catenin
    Wei Wei
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9041, USA
    Mol Cell Biol 31:4706-19. 2011
    ..Importantly, these findings suggest that Wnt activation is a more effective treatment for skeletal fragility than previously recognized that confers dual anabolic and anti-catabolic benefits...
  8. ncbi Macrophage VLDL receptor promotes PAFAH secretion in mother's milk and suppresses systemic inflammation in nursing neonates
    Yang Du
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    Nat Commun 3:1008. 2012
    ....
  9. ncbi PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss
    Wei Wei
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Cell Metab 11:503-16. 2010
    ..These findings identify PGC1beta as an essential mediator for the PPARgamma stimulation of osteoclastogenesis by targeting both PPARgamma itself and ERRalpha, thus activating two distinct transcriptional programs...
  10. ncbi Maternal western diet causes inflammatory milk and TLR2/4-dependent neonatal toxicity
    Yang Du
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    Genes Dev 26:1306-11. 2012
    ..These findings unravel maternal western diet-induced inflammatory milk secretion as a novel aspect of the metabolic syndrome at the maternal offspring interface...
  11. ncbi HDAC7 inhibits osteoclastogenesis by reversing RANKL-triggered β-catenin switch
    Zixue Jin
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    Mol Endocrinol 27:325-35. 2013
    ..003) owing to 102% elevated bone resorption (P = 0.01). These findings are clinically significant in light of the remarkable therapeutic potentials of HDAC inhibitors for several diseases such as cancer, diabetes, and neurodegeneration...
  12. ncbi The starvation hormone, fibroblast growth factor-21, extends lifespan in mice
    Yuan Zhang
    Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, United States
    elife 1:e00065. 2012
    ..These findings raise the possibility that FGF21 can be used to extend lifespan in other species.DOI:http://dx.doi.org/10.7554/eLife.00065.001...
  13. ncbi Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
    Wei Wei
    Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA
    PPAR Res 2011:867180. 2011
    ..This paper will focus on current new developments that implicate potential mechanisms for how PPARγ modulates skeletal homeostasis and how TZDs exert bone-loss side effects...